Filing Details

Accession Number:
0001144204-12-025572
Form Type:
4
Zero Holdings:
No
Publication Time:
2012-05-02 14:50:32
Reporting Period:
2012-05-02
Filing Date:
2012-05-02
Accepted Time:
2012-05-02 14:50:32
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1077183 Neogenomics Inc NGNM.OB Services-Testing Laboratories (8734) 742897368
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1518734 George Cardoza C/O Neogenomics, Inc.
12701 Commonwealth Drive Suite 9
Fort Myers FL US 33913
Chief Financial Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2012-05-02 4,000 $1.66 50,337 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 20,000 Indirect Trust by Self
Reported Derivative Holdings
Sec. Name Sec. Type Price Date Expiration Date Amount Remaning Holdings Nature of Ownership
Common Stock Stock option (Right to Buy) $1.55 2010-11-30 2014-11-29 0 150,000 Direct
Common Stock Stock option (Right to Buy) $1.46 2012-04-14 2016-04-13 0 100,000 Direct
Expiration Date Amount Remaning Holdings Nature of Ownership
2014-11-29 0 150,000 Direct
2016-04-13 0 100,000 Direct
Footnotes
  1. The amount includes exempt purchases made under the Company's stock purchase plan.
  2. On November 30, 2009 Mr. Cardoza was granted an option to purchase 150,000 shares. The options were all time based and vest ratable over each of Mr. Cardoza's first four anniversaries with the Company.
  3. On April 14, 2011 Mr. Cardoza was granted an option to purchase 100,000 shares. These options vest ratably at the first four anniversary dates of the grant.